BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 1692385)

  • 21. [Chronic myeloid leukemia--latest aspects and practical progress in recent years].
    Griesshammer M; Heimpel H
    Med Klin (Munich); 1995 Sep; 90(9):527-31. PubMed ID: 7476731
    [No Abstract]   [Full Text] [Related]  

  • 22. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
    Ganessan K; Goel R; Kumar K; Bakhshi S
    Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot study.
    Meloni G; Foà R; Tosti S; Vignetti M; Gavosto F; Mandelli F
    Haematologica; 1990; 75(6):502-5. PubMed ID: 2098290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular basis of chronic myelogenous leukemia and significance of diagnostic methods based on BCR-ABL gene amplification].
    Sacha T; Dulak J; Skotnicki AB; Dembińska-Kiec A
    Przegl Lek; 1999; 56 Suppl 1():57-61. PubMed ID: 10494184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cytogenetic and clinical features of Philadelphia chromosome positive leukemias].
    Becher R; Kloke O
    Verh Dtsch Ges Pathol; 1990; 74():36-42. PubMed ID: 1708614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J; Serrano J; Jiménez A; Castillejo JA; Reina ML; González MG; Rodríguez MC; García I; Sánchez J; Maldonado J; Torres A
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Donor buffy-coat infusion and chemotherapy for leukemia in relapse after marrow transplantation.
    Bogdanić V; Aurer I; Hitrec V; Boban D; Nemet D; Zupancić-Salek S; Labar B
    Haematologica; 1995; 80(4):338-40. PubMed ID: 7590504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An accelerrated-phase CML patient with e19a2 junction of BCR/ABL gene - the first case of transplanted CML with micro bcr.
    Polák J; Koza V; Cetkovský P; Haskovec C
    Bone Marrow Transplant; 2000 May; 25(10):1109-10. PubMed ID: 10828875
    [No Abstract]   [Full Text] [Related]  

  • 29. Recent advancements in the treatment of chronic myelogenous leukemia.
    O'Dwyer ME; Mauro MJ; Druker BJ
    Annu Rev Med; 2002; 53():369-81. PubMed ID: 11818480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. e6a2 BCR-ABL transcript in chronic myeloid leukemia: is it associated with aggressive disease?
    Colla S; Sammarelli G; Voltolini S; Crugnola M; Sebastio P; Giuliani N
    Haematologica; 2004 May; 89(5):611-3. PubMed ID: 15136228
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The biology of chronic myeloid leukemia.
    Faderl S; Talpaz M; Estrov Z; O'Brien S; Kurzrock R; Kantarjian HM
    N Engl J Med; 1999 Jul; 341(3):164-72. PubMed ID: 10403855
    [No Abstract]   [Full Text] [Related]  

  • 32. Coexistence of translocation(1,19) and the Philadelphia chromosome in a child's first presentation of chronic myeloid leukemia in blast crisis treated with dasatinib.
    Eckardt MA; Chang VY; Rao NP; Federman N
    Pediatr Hematol Oncol; 2011 Nov; 28(8):669-75. PubMed ID: 22023462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Case of Childhood Blastic Phase Chronic Myeloid Leukemia With Minor BCR-ABL.
    Yamanaka J; Shimizu M; Sato M; Inoue M; Matsui M; Shimada H; Shichino H
    J Pediatr Hematol Oncol; 2020 Aug; 42(6):e459-e462. PubMed ID: 30994506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances in prognosis of chronic myeloid leukemia.
    Baccarani M; Russo D; Fanin R; Zuffa E; Tura S
    Haematologica; 1992; 77(5):377-80. PubMed ID: 1483586
    [No Abstract]   [Full Text] [Related]  

  • 35. [Progress in the field of hematology in the last 100 years: Medical history of chronic myelogenous leukemia].
    Tomonaga M
    Nihon Naika Gakkai Zasshi; 2002 Jul; 91(7):2090-4. PubMed ID: 12187683
    [No Abstract]   [Full Text] [Related]  

  • 36. Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP-CML) exist? That is the question.
    Henry A; Bracquemart C; Naguib D; Chantepie S; Cheze S; Johnson-Ansah HA
    Br J Haematol; 2021 Nov; 195(3):469-471. PubMed ID: 34396510
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chronic myeloid leukemia].
    Matsuo T; Tomonaga M
    Nihon Rinsho; 2001 Nov; 59 Suppl 7():529-36. PubMed ID: 11808163
    [No Abstract]   [Full Text] [Related]  

  • 38. Extramedullary blast crisis in a patient with Philadelphia chromosome-positive chronic myelogenous leukemia in complete cytogenetic remission.
    O'Brien S; Witt R; Talpaz M; Kantarjian H
    Cancer; 1991 Apr; 67(7):1946-9. PubMed ID: 2004308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Philadelphia chromosome.
    Parikh PM; Iyer RS; Saikia TK; Gopal R; Advani SH
    J Assoc Physicians India; 1992 Feb; 40(2):98-100. PubMed ID: 1629147
    [No Abstract]   [Full Text] [Related]  

  • 40. NPM1 mutations occur rarely or not at all in chronic myeloid leukaemia patients in chronic phase or blast crisis.
    Watkins DB; Hughes TP; White DL; D'Andrea RJ
    Leukemia; 2013 Feb; 27(2):489-90. PubMed ID: 22791379
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.